Literature DB >> 18398616

Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review.

Ruo-Qi Hu1, Hashim Mehter, Tibor Nadasdy, Anjali Satoskar, Dan N Spetie, Brad H Rovin, Lee Hebert.   

Abstract

Severe hemorrhagic cystitis associated with oral cyclophosphamide (CYP) therapy has rarely been reported in the past 20 years, probably because this condition has largely disappeared because of the use of shorter courses of CYP, either oral or IV. Herein, we describe a patient who received 309 g of oral CYP over a 4-year period to treat Wegener's granulomatosis (WG) that initially involved brain, lung, and kidney. She came under our care for the first time when she presented with a one-day history of oliguria and passing blood clots. Severe hemorrhagic cystitis was present. It eventually required cystectomy. Despite her massive CYP exposure her kidney biopsy showed acute crescentic glomerulonephritis. She survived her acute illness only to die 2 months later of acute leukemia. This patient is a reminder that severe hemorrhagic cystitis from oral CYP still exists, and that WG can be resistant to even toxic doses of oral CYP. Alternative therapies are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398616     DOI: 10.1007/s00296-008-0581-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.

Authors:  U Specks; F C Fervenza; T J McDonald; M C Hogan
Journal:  Arthritis Rheum       Date:  2001-12

2.  Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis.

Authors:  T J Stillwell; R C Benson; R A DeRemee; T J McDonald; L H Weiland
Journal:  Arthritis Rheum       Date:  1988-04

3.  Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.

Authors:  T J Stillwell; R C Benson
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

4.  Therapy in cytoxan hemorrhagic cystitis.

Authors:  R P Pauwels; W A Moonen
Journal:  Urol Int       Date:  1970       Impact factor: 2.089

5.  Cyclophosphamide and severe hemorrhagic cystitis.

Authors:  A M Hutter; A W Bauman; I N Frank
Journal:  N Y State J Med       Date:  1969-01-15

6.  Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement.

Authors:  R Nowack; U Göbel; P Klooker; O Hergesell; K Andrassy; F J van der Woude
Journal:  J Am Soc Nephrol       Date:  1999-09       Impact factor: 10.121

7.  Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation.

Authors:  S Koc; H Hagglund; R C Ireton; J A Perez-Simon; S J Collins; F R Appelbaum
Journal:  Bone Marrow Transplant       Date:  2000-10       Impact factor: 5.483

8.  Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.

Authors:  Wilhelm H Schmitt; E Christiaan Hagen; Irmgard Neumann; Rainer Nowack; Luis Felipe Flores-Suárez; Fokko J van der Woude
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

Review 9.  Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

Authors:  Philip J Klemmer; W Chalermskulrat; Michael S Reif; Susan L Hogan; David C Henke; Ronald J Falk
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

Review 10.  Wegener's granulomatosis: current and upcoming therapies.

Authors:  Carol A Langford
Journal:  Arthritis Res Ther       Date:  2003-05-29       Impact factor: 5.156

View more
  5 in total

1.  Cyclophosphamide Induces an Early Wave of Acrolein-Independent Apoptosis in the Urothelium.

Authors:  Francis M Hughes; Alexa G Corn; Andrew R Nimmich; Jeffery D Pratt-Thomas; J Todd Purves
Journal:  Adv Biosci Biotechnol       Date:  2013-08

2.  Inflammation and pyroptosis mediate muscle expansion in an interleukin-1β (IL-1β)-dependent manner.

Authors:  Subhash Haldar; Christopher Dru; Diptiman Choudhury; Rajeev Mishra; Ana Fernandez; Shea Biondi; Zhenqiu Liu; Kenichi Shimada; Moshe Arditi; Neil A Bhowmick
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

3.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

4.  Bladder Cancer versus Hemorrhagic Cystitis: A Case of Mistaken Identity in a 34-Year-Old Male Undergoing Therapy for Granulomatosis with Polyangiitis.

Authors:  Jonathan Amatruda; Kevin Dieckhaus; Poornima Hegde; John Taylor
Journal:  Case Rep Nephrol Urol       Date:  2014-06-04

5.  Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis.

Authors:  Pradeep Tyagi; Vikas Tyagi; Naoki Yoshimura; Erich Witteemer; Derek Barclay; Patricia A Loughran; Ruben Zamora; Yoram Vodovotz
Journal:  J Inflamm (Lond)       Date:  2009-08-19       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.